|Bid||160.00 x 100|
|Ask||160.02 x 100|
|Day's Range||157.25 - 161.76|
|52 Week Range||71.46 - 167.00|
|PE Ratio (TTM)||223.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
It's well-known that technology stocks are leading the advance in the S&P 500, but health care stocks are close behind.
Vertex Pharmaceuticals research results ignited a strong biotech sector advance that could gain traction in coming weeks.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) had an incredible day on Wednesday spiking over 20% on a favorable headline regarding drug trials. This is especially true when the stock jumps as much as VRTX stock jumped on Wednesday. Compare this to the recent jump in Alibaba Group Holding Ltd (NYSE:BABA) where management actually gave us the math behind the higher valuations.